Effect of EGCG On Fe(III)‐induced conformational transition of silk fibroin, a model of protein related to neurodegenerative diseases
暂无分享,去创建一个
Yuan Zhang | Lihui Xu | P. Zhou | Cong-heng Chen | Sidong Tu | Juan Zhao
[1] P. Zhou,et al. Effect of Al(III) and curcumin on silk fibroin conformation and aggregation morphology , 2014 .
[2] R. Ortega,et al. Copper pathology in vulnerable brain regions in Parkinson's disease , 2014, Neurobiology of Aging.
[3] O. Phillipson. Management of the aging risk factor for Parkinson's disease , 2014, Neurobiology of Aging.
[4] B. Meier,et al. Structural and functional characterization of two alpha-synuclein strains , 2013, Nature Communications.
[5] H. Kozłowski,et al. Specific metal ion binding sites in unstructured regions of proteins , 2013 .
[6] Z. Tao,et al. Epigallocatechin-gallate (EGCG) regulates autophagy in human retinal pigment epithelial cells: a potential role for reducing UVB light-induced retinal damage. , 2013, Biochemical and biophysical research communications.
[7] M. Kaplan,et al. Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis. , 2013, Life sciences.
[8] J. H. Viles,et al. Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer's, Parkinson's and prion diseases , 2012 .
[9] Marek Luczkowski,et al. Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases) , 2012 .
[10] T. Härd,et al. Inhibition of amyloid formation. , 2012, Journal of molecular biology.
[11] Ping Zhou,et al. Trehalose inhibits fibrillation of A53T mutant alpha-synuclein and disaggregates existing fibrils. , 2012, Archives of biochemistry and biophysics.
[12] Yue Zhang,et al. Interference of EGCG on the Zn(II)-induced conformational transition of silk fibroin as a model protein related to neurodegenerative diseases , 2012 .
[13] D. Raleigh,et al. Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. , 2012, Biochemistry.
[14] E. Masliah,et al. Protein aggregate spreading in neurodegenerative diseases: Problems and perspectives , 2011, Neuroscience Research.
[15] D. Knight,et al. The Role of Mn(II) in Silk Fibroin Based on EPR and NMR Spectroscopy , 2011 .
[16] T. Lefèvre,et al. Diversity of molecular transformations involved in the formation of spider silks. , 2011, Journal of molecular biology.
[17] J. S. Pedersen. The Nature of Amyloid-like Glucagon Fibrils , 2010, Journal of diabetes science and technology.
[18] M. Valko,et al. Metals, oxidative stress and neurodegenerative disorders , 2010, Molecular and Cellular Biochemistry.
[19] M. Biancalana,et al. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. , 2010, Biochimica et biophysica acta.
[20] D. Ehrnhoefer,et al. EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity , 2010, Proceedings of the National Academy of Sciences.
[21] You-nian Liu,et al. Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes. , 2010, Journal of inorganic biochemistry.
[22] Yibin Deng,et al. Folding process of silk fibroin induced by ferric and ferrous ions , 2009 .
[23] Nathan R. Perron,et al. A Review of the Antioxidant Mechanisms of Polyphenol Compounds Related to Iron Binding , 2009, Cell Biochemistry and Biophysics.
[24] D. Ehrnhoefer,et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers , 2008, Nature Structural &Molecular Biology.
[25] C. Ross,et al. Single Particle Characterization of Iron-induced Pore-forming α-Synuclein Oligomers* , 2008, Journal of Biological Chemistry.
[26] William C. Nolan,et al. Curcumin inhibits aggregation of α-synuclein , 2008, Acta Neuropathologica.
[27] Bharathi,et al. Copper- and iron-induced differential fibril formation in α-synuclein: TEM study , 2007, Neuroscience Letters.
[28] Paul W. Ryan,et al. The kinetics and mechanisms of the complex formation and antioxidant behaviour of the polyphenols EGCg and ECG with iron(III). , 2007, Journal of inorganic biochemistry.
[29] Charles Ramassamy,et al. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. , 2006, European journal of pharmacology.
[30] I. McKeith,et al. Pathophysiology of synuclein aggregation in Lewy body disease , 2006, Mechanisms of Ageing and Development.
[31] David Morgan,et al. Green Tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice , 2005, The Journal of Neuroscience.
[32] Jun Hu,et al. Inhibition of α‐synuclein fibrillization by dopamine analogs via reaction with the amino groups of α‐synuclein , 2005 .
[33] K. Tipton,et al. Electrochemical investigation into the redox activity of Fe(II)/Fe(III) in the presence of nicotine and possible relations to neurodegenerative diseases. , 2004, Biochimica et biophysica acta.
[34] Z. Shao,et al. Effect of pH and copper(II) on the conformation transitions of silk fibroin based on EPR, NMR, and Raman spectroscopy. , 2004, Biochemistry.
[35] G. Hadjigeorgiou,et al. Protein misfolding in neurodegenerative diseases , 2004, Neuropathology and applied neurobiology.
[36] Vladimir N Uversky,et al. A Protein-Chameleon: Conformational Plasticity of α-Synuclein, a Disordered Protein Involved in Neurodegenerative Disorders , 2003, Journal of biomolecular structure & dynamics.
[37] T. Ban,et al. Direct Observation of Amyloid Fibril Growth Monitored by Thioflavin T Fluorescence* 210 , 2003, The Journal of Biological Chemistry.
[38] S. Khokhar,et al. Iron binding characteristics of phenolic compounds: some tentative structure–activity relations , 2003 .
[39] Z. Shao,et al. The natural silk spinning process , 2001 .
[40] V. Uversky,et al. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. , 2001, The Journal of biological chemistry.
[41] S. Lindquist,et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.
[42] M. Jacquet,et al. Fine organization of Bombyx mori fibroin heavy chain gene. , 2000, Nucleic acids research.
[43] Yongcheng Liu,et al. PIXE analysis of silk , 1997 .
[44] K. Bötzel,et al. Generation of ferric iron links oxidative stress to α-synuclein oligomer formation. , 2011, Journal of Parkinson's disease.
[45] D. Valenti,et al. Alzheimer's disease: visual system review. , 2010, Optometry.
[46] Ş. Sungur,et al. Investigation of complexes tannic acid and myricetin with Fe(III). , 2008, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[47] P. Lansbury,et al. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.